EMA shortages Shortage ongoing Medicine shortages
ADHD medicines — supply shortage (shortage ongoing)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
ADHD medicines
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): atomoxetine;methylphenidate;lisdexamfetamine
- Therapeutic area: Attention Deficit Disorder with Hyperactivity
- Pharmaceutical forms affected: Various presentations in various strengths
- Expected resolution: Depending on the medicine and the EEA country, the shortage may continue until the end of 2025.
- Last updated: 20/11/2025
Measures and alternatives
- Availability of alternatives: Yes
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗